How many institutions held CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in Q1 2021?

88 institutional investors reported CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share for Q1 2021. Use the holders table for investor-level position and value details.

Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

Q: What does CUSIP 22978P106 represent in this 13F holders report?

CUSIP 22978P106 is the security identifier for CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 22978P106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 43,411,663
Total 13F shares: 18,817,560
Share change: -514,358
Total reported value: $229,653,033
Put/Call ratio: 424%
Price per share: $12.20
Number of holders: 88
Value change: -$6,452,286
Number of buys: 34
Number of sells: 46

Quarterly Holders Quick Answers

What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 22978P106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Nantahala Capital Management, LLC	13F	Company	5.8%	2,506,772	$31,360,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	5%	2,162,978	$27,059,000	—	31 Dec 2020	13F
Corriente Advisors, LLC	13F	Company	4.4%	1,915,219	$23,959,000	—	31 Dec 2020	13F
Slate Path Capital LP	13F	Company	3.4%	1,483,619	$18,560,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	3.3%	1,444,537	$18,070,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	3.2%	1,391,578	$17,409,000	—	31 Dec 2020	13F
Prosight Management, LP	13F	Company	2.1%	906,569	$11,341,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	1.3%	544,062	$6,806,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.2%	513,370	$6,422,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	1.2%	510,088	$6,381,000	—	31 Dec 2020	13F
Robertson Stephens Wealth Management, LLC	13F	Company	1.1%	484,000	$6,054,000	—	31 Dec 2020	13F
Avoro Capital Advisors LLC	13F	Company	1%	452,500	$5,661,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.99%	430,663	$5,387,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.84%	362,523	$4,535,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.81%	350,700	$4,387,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.79%	343,745	$4,300,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.75%	325,000	$4,066,000	—	31 Dec 2020	13F
683 Capital Management, LLC	13F	Company	0.74%	320,000	$4,003,000	—	31 Dec 2020	13F
Voss Capital, LP	13F	Company	0.51%	220,714	$2,761,000	—	31 Dec 2020	13F
SANDERS MORRIS HARRIS LLC	13F	Company	0.45%	193,591	$2,449,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.42%	184,421	$2,308,000	—	31 Dec 2020	13F
PRECEPT MANAGEMENT LLC	13F	Company	0.35%	150,000	$1,877,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.33%	142,361	$1,781,000	—	31 Dec 2020	13F
P.A.W. CAPITAL CORP	13F	Company	0.32%	140,000	$1,751,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.26%	114,946	$1,438,000	—	31 Dec 2020	13F
Rock Creek Group, LP	13F	Company	0.23%	100,014	$1,251,000	—	31 Dec 2020	13F
Carlson Capital, L.P.	13F	Company	0.2%	85,000	$1,063,000	—	31 Dec 2020	13F
Bleichroeder LP	13F	Company	0.17%	75,000	$938,000	—	31 Dec 2020	13F
Sigma Planning Corp	13F	Company	0.16%	71,576	$895,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.16%	68,300	$854,000	—	31 Dec 2020	13F
STIFEL FINANCIAL CORP	13F	Company	0.15%	65,886	$824,000	—	31 Dec 2020	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.15%	64,297	$804,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.15%	63,739	$797,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.14%	62,800	$786,000	—	31 Dec 2020	13F
APOGEM CAPITAL LLC	13F	Company	0.13%	56,035	$701,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.13%	55,438	$694,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.12%	53,400	$668,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.12%	52,617	$658,000	—	31 Dec 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.12%	50,897	$636,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	44,311	$554,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	0.09%	37,846	$473,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	37,651	$471,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.08%	34,933	$437,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.07%	31,900	$399,000	—	31 Dec 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.07%	31,278	$391,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	28,427	$356,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.06%	27,850	$348,000	—	31 Dec 2020	13F
ClariVest Asset Management LLC	13F	Company	0.06%	27,100	$339,000	—	31 Dec 2020	13F
Squarepoint Ops LLC	13F	Company	0.06%	26,205	$328,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.06%	25,400	$318,000	—	31 Dec 2020	13F

Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2021

As of 31 Mar 2021, Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,817,560 shares. The largest 10 holders included Nantahala Capital Management, LLC, Corriente Advisors, LLC, BlackRock Inc., VANGUARD GROUP INC, Slate Path Capital LP, STATE STREET CORP, GOLDMAN SACHS GROUP INC, Prosight Management, LP, GEODE CAPITAL MANAGEMENT, LLC, and Robertson Stephens Wealth Management, LLC. This page lists 88 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

-6

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.